In 2022, your generosity fueled Lustgarten-funded researchers’ significant progress in pancreatic cancer research. Together, we are advancing research from the laboratory to the clinic faster than ever before, giving renewed […]
The American Cancer Society (ACS) has released its Cancer Facts & Figures 2023, an annual summary of the current scientific information about cancer. The report highlighted progress in the five-year […]
This is a randomized multicentre phase II trial with a large translational component. The trial will evaluate the two standard chemotherapy regimens: modified folfirinox (mFFX) and gemcitabine/nab-paclitaxel (GA), in patients […]
A report compiled by the National Cancer Institute, the Centers for Disease Control and Prevention, the American Cancer Society, and the North American Association of Central Cancer Registries, Annual Report […]
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
Live-streamed webinar series created to introduce you to best-in-class experts from the field of pancreatic cancer research, technology, and science.
Our hearts are broken, our friend and NBA referee extraordinaire, Tony Brown, passed away this past Thursday from stage IV pancreatic cancer. The shock of his diagnosis only spurred Tony’s […]
Cold Spring Harbor Laboratory (CSHL) Professor and Cancer Center Director David Tuveson was elected to the National Academy of Medicine (NAM) on October 17, 2022. He was recognized for his leadership in pancreatic cancer […]